AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 81 min read$ARQQ

Feenan Paul sold $12K of ARQQ

Feenan Paul (Chief Revenue Officer) sold 504 shares of Arqit Quantum Inc. (ARQQ) at $24.19 on 2026-10-06.

Original reporting
SEC EDGAR · Feenan Paul
Published Oct 8, 2026, 10:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 10:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ARQQ
Neutral
high confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQNeutralLow
01

Why it matters

The transaction is a routine insider sale with minimal market impact.

02

Market read

Small insider sell; unlikely to affect price materially.

03

What to watch

No additional context on why the shares were sold; could be tax or liquidity driven.

Relevance 3/10Novelty 3/10Timing: today

Background

Form 4 disclosures provide transparent reporting of insider transactions required by the SEC.

Company-level read

Ticker impact

$ARQQNeutralHigh confidence
Context

Chief Revenue Officer sold 504 shares for $12,192, reducing his stake to 20,912 shares.

Expected impact

likely slight pressure as the market prices in the small sell-off

Evidence & confidence

Form 4 filing is primary source, but the transaction size is trivial for a mid‑cap issuer.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

The sale could be interpreted as a signal of confidence if the insider retains a large position.

Key entities

  • company
    Arqit Quantum Inc.

    Quantum communications firm listed on Nasdaq under ARQQ.

  • person
    Feenan Paul

    Chief Revenue Officer of Arqit Quantum Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ARQQ insider trading history →

Related articles

JUN 4
$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

finance.yahoo.com4 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min